Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of GBP 203.02 billion. The enterprise value is 223.43 billion.
Market Cap | 203.02B |
Enterprise Value | 223.43B |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Shares Outstanding | n/a |
Shares Change (YoY) | +0.28% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.53B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.10, with an EV/FCF ratio of 21.48.
EV / Earnings | 20.56 |
EV / Sales | 4.64 |
EV / EBITDA | 12.10 |
EV / EBIT | 14.68 |
EV / FCF | 21.48 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.87.
Current Ratio | 1.47 |
Quick Ratio | 0.93 |
Debt / Equity | 0.87 |
Debt / EBITDA | 1.58 |
Debt / FCF | 2.87 |
Interest Coverage | 15.94 |
Financial Efficiency
Return on equity (ROE) is 33.38% and return on invested capital (ROIC) is 15.73%.
Return on Equity (ROE) | 33.38% |
Return on Assets (ROA) | 11.38% |
Return on Capital (ROIC) | 15.73% |
Revenue Per Employee | 696,318 |
Profits Per Employee | 153,083 |
Employee Count | 72,000 |
Asset Turnover | 0.58 |
Inventory Turnover | 2.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.56% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -35.56% |
50-Day Moving Average | 61.06 |
200-Day Moving Average | 67.86 |
Relative Strength Index (RSI) | 27.35 |
Average Volume (20 Days) | 12,929 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.63 |
Income Statement
In the last 12 months, Merck & Co. had revenue of GBP 49.44 billion and earned 10.87 billion in profits. Earnings per share was 4.26.
Revenue | 49.44B |
Gross Profit | 37.47B |
Operating Income | 15.64B |
Pretax Income | 12.07B |
Net Income | 10.87B |
EBITDA | 18.70B |
EBIT | 15.64B |
Earnings Per Share (EPS) | 4.26 |
Balance Sheet
The company has 8.98 billion in cash and 29.90 billion in debt, giving a net cash position of -20.92 billion.
Cash & Cash Equivalents | 8.98B |
Total Debt | 29.90B |
Net Cash | -20.92B |
Net Cash Per Share | n/a |
Equity (Book Value) | 34.54B |
Book Value Per Share | 13.60 |
Working Capital | 9.61B |
Cash Flow
In the last 12 months, operating cash flow was 13.21 billion and capital expenditures -2.80 billion, giving a free cash flow of 10.40 billion.
Operating Cash Flow | 13.21B |
Capital Expenditures | -2.80B |
Free Cash Flow | 10.40B |
FCF Per Share | n/a |
Margins
Gross margin is 75.79%, with operating and profit margins of 31.64% and 21.98%.
Gross Margin | 75.79% |
Operating Margin | 31.64% |
Pretax Margin | 24.41% |
Profit Margin | 21.98% |
EBITDA Margin | 37.82% |
EBIT Margin | 31.64% |
FCF Margin | 21.04% |
Dividends & Yields
Merck & Co. does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 55.64% |
Buyback Yield | -0.28% |
Shareholder Yield | -0.28% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.57.
Altman Z-Score | 4.57 |
Piotroski F-Score | n/a |